Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review

Overview of attention for article published in Cancer Immunology, Immunotherapy, May 1993

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 82 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

TREATMENT INVOLVING INTERLEUKIN-2 (IL2) AND INTERFERON (IFN)

Application WO-2020200481-A1

World Intellectual Property Organisation (WIPO)

TREATMENT USING CYTOKINE ENCODING RNA

Application WO-2019154985-A1

World Intellectual Property Organisation (WIPO)

Immobilized tumor necrosis factor-α muteins for enhancing immune response in mammals

Grant US-8501918-B2

United States of America